198 related articles for article (PubMed ID: 18801571)
1. Inhibition of Taq polymerase as a method for screening heparin for oversulfated contaminants.
Tami C; Puig M; Reepmeyer JC; Ye H; D'Avignon DA; Buhse L; Verthelyi D
Biomaterials; 2008 Dec; 29(36):4808-14. PubMed ID: 18801571
[TBL] [Abstract][Full Text] [Related]
2. Identification of a simple and sensitive microplate method for the detection of oversulfated chondroitin sulfate in heparin products.
Bairstow S; McKee J; Nordhaus M; Johnson R
Anal Biochem; 2009 May; 388(2):317-21. PubMed ID: 19289093
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
[TBL] [Abstract][Full Text] [Related]
4. One-hour screening of adulterated heparin by simplified peroxide digestion and fast RPIP-LC-MS(2).
Li H; Wickramasekara S; Nemes P
Anal Chem; 2015 Aug; 87(16):8424-32. PubMed ID: 26168275
[TBL] [Abstract][Full Text] [Related]
5. Analysis of heparin sodium by SAX/HPLC for contaminants and impurities.
Trehy ML; Reepmeyer JC; Kolinski RE; Westenberger BJ; Buhse LF
J Pharm Biomed Anal; 2009 Apr; 49(3):670-3. PubMed ID: 19167854
[TBL] [Abstract][Full Text] [Related]
6. Detection of possible economically motivated adulterants in heparin sodium and low molecular weight heparins with a colorimetric microplate based assay.
Sommers CD; Keire DA
Anal Chem; 2011 Sep; 83(18):7102-8. PubMed ID: 21819047
[TBL] [Abstract][Full Text] [Related]
7. An assessment of polydispersed species in unfractionated and low molecular weight heparins by diffusion ordered nuclear magnetic resonance spectroscopy method.
Bednarek E; Sitkowski J; Bocian W; Mulloy B; Kozerski L
J Pharm Biomed Anal; 2010 Nov; 53(3):302-8. PubMed ID: 20417048
[TBL] [Abstract][Full Text] [Related]
8. Determination of oversulfated chondroitin sulfate and dermatan sulfate impurities in heparin by capillary electrophoresis.
Somsen GW; Tak YH; ToraƱo JS; Jongen PM; de Jong GJ
J Chromatogr A; 2009 May; 1216(18):4107-12. PubMed ID: 19272607
[TBL] [Abstract][Full Text] [Related]
9. New developments in quantitative polymerase chain reaction applied to control the quality of heparins.
Auguste C; Dereux S; Martinez C; Anger P
Anal Bioanal Chem; 2011 Jan; 399(2):747-55. PubMed ID: 20931175
[TBL] [Abstract][Full Text] [Related]
10. Case study: contamination of heparin with oversulfated chondroitin sulfate.
Chess EK; Bairstow S; Donovan S; Havel K; Hu P; Johnson RJ; Lee S; McKee J; Miller R; Moore E; Nordhaus M; Ray J; Szabo C; Wielgos T
Handb Exp Pharmacol; 2012; (207):99-125. PubMed ID: 22566223
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin.
Viskov C; Bouley E; Hubert P; Martinez C; Herman F; Jeske W; Hoppensteadt D; Walenga JM; Fareed J
Clin Appl Thromb Hemost; 2009; 15(4):395-401. PubMed ID: 19617248
[TBL] [Abstract][Full Text] [Related]
12. Oversulfated chondroitin sulfate-E binds to BMP-4 and enhances osteoblast differentiation.
Miyazaki T; Miyauchi S; Tawada A; Anada T; Matsuzaka S; Suzuki O
J Cell Physiol; 2008 Dec; 217(3):769-77. PubMed ID: 18720384
[TBL] [Abstract][Full Text] [Related]
13. Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants.
Zang Q; Keire DA; Wood RD; Buhse LF; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
J Pharm Biomed Anal; 2011 Apr; 54(5):1020-9. PubMed ID: 21215547
[TBL] [Abstract][Full Text] [Related]
14. Method to detect contaminants in heparin using radical depolymerization and liquid chromatography-mass spectrometry.
Li G; Cai C; Li L; Fu L; Chang Y; Zhang F; Toida T; Xue C; Linhardt RJ
Anal Chem; 2014 Jan; 86(1):326-30. PubMed ID: 24364596
[TBL] [Abstract][Full Text] [Related]
15. A nanosensor for ultrasensitive detection of oversulfated chondroitin sulfate contaminant in heparin.
Kalita M; Balivada S; Swarup VP; Mencio C; Raman K; Desai UR; Troyer D; Kuberan B
J Am Chem Soc; 2014 Jan; 136(2):554-7. PubMed ID: 24127748
[TBL] [Abstract][Full Text] [Related]
16. Assessment of oversulfated chondroitin sulfate in low molecular weight and unfractioned heparins diffusion ordered nuclear magnetic resonance spectroscopy method.
Sitkowski J; Bednarek E; Bocian W; Kozerski L
J Med Chem; 2008 Dec; 51(24):7663-5. PubMed ID: 19055319
[TBL] [Abstract][Full Text] [Related]
17. Heparin identification test and purity test for OSCS in heparin sodium and heparin calcium by weak anion-exchange high-performance liquid chromatography.
Hashii N; Kawasaki N; Itoh S; Qin Y; Fujita N; Hattori T; Miyata K; Bando A; Sekimoto Y; Hama T; Kashimura M; Tatsumi M; Mabuchi K; Namekawa H; Sakai T; Hirose M; Dobashi S; Shimahashi H; Koyama S; Herr SO; Kawai K; Yoden H; Yamaguchi T
Biologicals; 2010 Sep; 38(5):539-43. PubMed ID: 20452241
[TBL] [Abstract][Full Text] [Related]
18. Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008.
McMahon AW; Pratt RG; Hammad TA; Kozlowski S; Zhou E; Lu S; Kulick CG; Mallick T; Dal Pan G
Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):921-33. PubMed ID: 20661880
[TBL] [Abstract][Full Text] [Related]
19. Structure elucidation and biological activity of the oversulfated chondroitin sulfate contaminant in Baxter heparin.
McKee J; Bairstow S; Szabo C; Ray J; Wielgos T; Hu P; Chess E; Nordhaus M; Hai T; Campbell J; Donovan S; Viseux N; Riedel N; Cammack J; Johnson R
J Clin Pharmacol; 2010 Oct; 50(10):1159-70. PubMed ID: 20147614
[TBL] [Abstract][Full Text] [Related]
20. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events.
Guerrini M; Beccati D; Shriver Z; Naggi A; Viswanathan K; Bisio A; Capila I; Lansing JC; Guglieri S; Fraser B; Al-Hakim A; Gunay NS; Zhang Z; Robinson L; Buhse L; Nasr M; Woodcock J; Langer R; Venkataraman G; Linhardt RJ; Casu B; Torri G; Sasisekharan R
Nat Biotechnol; 2008 Jun; 26(6):669-75. PubMed ID: 18437154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]